Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing 24-hour closed-loop insulin delivery (artificial pancreas) in adults and adolescents with type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED